Bacterin International, Inc. Secures Additional OrbiMed Financing

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, announced the closing of an additional $4 million financing from OrbiMed.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC